Life Summary
Kee Woo-sung is Vice Chairman and CEO of Celltrion.

He is focusing on expanding the company’s core biosimilar business while strengthening its capabilities in new drug development.

He was born on December 10, 1961, by the lunar calendar.

He graduated from Seoul Joongdong High School and the Department of Industrial Engineering at Hanyang University.

He began his professional career in the planning office of Daewoo Motor.

As a founding member of Nexol Biotech, the predecessor of Celltrion, he was deeply involved in the development of the world’s first antibody biosimilar, Remsima, and its European approval process, and is regarded as a key figure who led Celltrion’s growth.

After serving as head of the Production Support Division and head of the Product Development Division, he was appointed CEO in 2015 and secured his fourth consecutive term at the shareholders’ meeting in 2023.

He is considered one of Chairman Seo Jung-jin’s closest associates.

#Celltrion #KeeWooSung #biosimilar #biopharmaceuticals #Remsima #antibodybiosimilar #newdrugdevelopment #Koreanbiotech #pharmaceuticalindustry #corporateleadership